NexGels Earnings Miss Signal Persistent Struggles, Not a Turnaround

NexGel reported mixed results in its fiscal 2025 Q4 earnings, with revenue declining and losses widening compared to the same period in the prior year. The report highlights the company's ongoing challenges amid a deteriorating financial performance and negative investor sentiment, as reflected in its recent stock price action.

Revenue

NexGel's total revenue for 2025 Q4 stood at $2.80 million, reflecting an 8.1% decrease from $3.04 million in 2024 Q4. The decline underscores ongoing pressure on the company's core business, with no specific segment revenue data provided in the report.

Earnings/Net Income

The company's earnings continued to trend downward, with a loss per share widening to $0.19 from $0.18 in the prior year. The net loss for 2025 Q4 reached $-928,000, an increase of 12.6% from $-824,000 in 2024 Q4. This is the sixth consecutive year of losses for NexGel in the corresponding fiscal quarter, signaling persistent financial headwinds and a lack of progress in achieving profitability.

The earnings per share performance is clearly negative, indicating a continued struggle in turning the business around. Investors have yet to see meaningful improvement in the company’s financial metrics.

Price Action

NexGel’s stock experienced mixed price action in the recent period. While the stock rose slightly by 0.64% during the latest trading day, it declined by 7.17% during the most recent full trading week. Over the past month, the stock has fallen sharply by 44.96%, reflecting investor concerns about the company’s outlook.

Post-Earnings Price Action Review

The strategy of purchasing NexGel shares following the release of a disappointing Q4 revenue report and holding them for 30 days led to underperformance. This approach resulted in a compound annual growth rate (CAGR) of -23.34% and a maximum drawdown of 87.09%, indicating substantial losses and high volatility. The Sharpe ratio of -0.28 and an excess return of -105.70% further highlight the poor risk-adjusted performance, demonstrating that the investment failed to generate any positive returns or deliver meaningful value to investors.

CEO Commentary

In the rescheduled earnings call, NexGel’s CEO, who also serves as the Chief Executive Officer and is deeply involved in the company’s strategic direction, expressed cautious optimism amid the company's ongoing challenges. The CEO acknowledged the revenue decline and worsening losses but highlighted the importance of the previously announced proposed transaction with Celularity as a potential turning point. “We remain focused on strengthening our balance sheet and exploring strategic opportunities that can unlock long-term value for our shareholders,” the CEO stated. While the company has faced six consecutive quarters of losses, the CEO emphasized the importance of navigating current market conditions with discipline and innovation. The tone of the comments was largely cautious, reflecting the need for patience as the company works to implement changes and pursue new opportunities.

Guidance

The company did not provide forward-looking guidance during the call. The CEO and leadership team focused primarily on the strategic implications of the proposed Celularity transaction and did not offer specific quantitative targets or qualitative expectations for future performance.

Additional News

NexGel announced the rescheduling of its Q4 2025 financial results call to April 8, 2026, at 4:30 P.M. ET. This delay was to allow additional time to provide shareholders with detailed updates on the previously announced proposed transaction with Celularity, a move that could reshape the company's strategic direction. The rescheduled call will offer investors a more comprehensive outlook as the company seeks to communicate its long-term vision. Investors were also informed that NexGel has filed its annual report on Form 10-K with the SEC, providing transparency into its financial position and operations.